Management of small (T1–T2) anal margin squamous cell carcinoma: clinical outcomes following local excision alone

Abstract

AbstractAimSquamous cell carcinomas of the anus are normally treated with synchronous chemoradiotherapy (CRT). Small, localized anal margin tumours may be adequately treated by local excision (LE) alone. This study aims to investigate the outcomes of patients with anal margin tumours treated with LE alone, reserving the use of CRT for salvage on local recurrence (LR).MethodsPatients with small, localized (stage I/IIA) anal margin tumours treated by LE from October 1999 to September 2018 were identified. The effect of tumour size and resection margin on LR risk was analysed. Outcomes of overall survival and disease‐free survival were measured.ResultsFifty‐five patients with anal margin tumours were identified. Overall 5‐year LR, overall survival and disease‐free survival rates were 8%, 86% and 82% respectively. Of the seven LRs, five were successfully salvaged with CRT with no further recurrence and two were not fit for CRT. Resection margins in non‐fragmented tumours and tumour size did not significantly influence LR risk.ConclusionsMost small, localized anal margin tumours can be adequately treated by LE alone with low LR rates. Most patients who developed LR were salvaged using CRT, with no cancer‐related deaths reported.